The proportion of HBV-positive cells offering insights into infection status and identifying patients more likely to achieve a cure. This complements traditional serological markers offering a more nuanced view of CHB infection dynamics and supporting personalized treatment strategies.
Countstar Connection
Single-cell suspensions underwent fluorescence-based cell assessment with Countstar (model not specified) before single-cell analysis in the 2025 Journal of translational medicine study.
